- Home
- OFLX vs CKPT Comparison
OFLX vs CKPT Comparison
Compare OFLX & CKPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFLX
- CKPT
- Stock Information
- Founded
- OFLX 1975
- CKPT 2014
- Country
- OFLX United States
- CKPT United States
- Employees
- OFLX N/A
- CKPT N/A
- Industry
- OFLX Industrial Specialties
- CKPT Biotechnology: Pharmaceutical Preparations
- Sector
- OFLX Industrials
- CKPT Health Care
- Exchange
- OFLX Nasdaq
- CKPT Nasdaq
- Market Cap
- OFLX 374.3M
- CKPT 335.9M
- IPO Year
- OFLX 2005
- CKPT 2017
- Fundamental
- Price
- OFLX $29.20
- CKPT $4.04
- Analyst Decision
- OFLX
- CKPT Buy
- Analyst Count
- OFLX 0
- CKPT 3
- Target Price
- OFLX N/A
- CKPT $4.33
- AVG Volume (30 Days)
- OFLX 31.1K
- CKPT 1.7M
- Earning Date
- OFLX 04-30-2025
- CKPT 05-09-2025
- Dividend Yield
- OFLX 4.63%
- CKPT N/A
- EPS Growth
- OFLX N/A
- CKPT N/A
- EPS
- OFLX 1.78
- CKPT N/A
- Revenue
- OFLX $101,681,000.00
- CKPT $41,000.00
- Revenue This Year
- OFLX N/A
- CKPT $102,182.93
- Revenue Next Year
- OFLX N/A
- CKPT $351.71
- P/E Ratio
- OFLX $16.36
- CKPT N/A
- Revenue Growth
- OFLX N/A
- CKPT N/A
- 52 Week Low
- OFLX $29.04
- CKPT $1.38
- 52 Week High
- OFLX $68.50
- CKPT $4.50
- Technical
- Relative Strength Index (RSI)
- OFLX 24.42
- CKPT 63.60
- Support Level
- OFLX $29.47
- CKPT $3.94
- Resistance Level
- OFLX $31.14
- CKPT $4.06
- Average True Range (ATR)
- OFLX 1.55
- CKPT 0.05
- MACD
- OFLX -0.33
- CKPT -0.03
- Stochastic Oscillator
- OFLX 2.44
- CKPT 83.33
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States.
About CKPT Checkpoint Therapeutics Inc.
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.